Get startedLog in
    Picture of IPI Legacy Liquidation Co logo

    IMPLQ — IPI Legacy Liquidation Co News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Impel Pharmaceuticals Announces First Quarter 2022 Financial Results

    Picture of IPI Legacy Liquidation Co logoIPI Legacy Liquidation Co
    16/05/2022 13:15
    May 16 (Reuters) - Impel Pharmaceuticals Inc  IMPL.O :
    * IMPEL PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q1 NON-GAAP LOSS PER SHARE $1.17
    * IMPEL PHARMACEUTICALS INC - FINANCING AGREEMENT WITH
OAKTREE
CAPITAL EXTENDS CASH RUNWAY INTO 2024
    * IMPEL PHARMACEUTICALS INC - NON-GAAP NET LOSS PER SHARE
FOR Q1
2022 WERE $1.17

Source text for Eikon:  ID:nGNX93bLvJ 
Further company coverage:  IMPL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on IPI Legacy Liquidation Co

    See all news